Literature DB >> 17512307

Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations.

John J Lima1, Hua Feng, Laurie Duckworth, Jianwei Wang, James E Sylvester, Niranjan Kissoon, Hardesh Garg.   

Abstract

Genes involved in the regulation of catecholamine function may be important in obesity because of the role catecholamines play in energy expenditure and lipolysis. To determine if common single nucleotide polymorphisms (SNPs) in beta(1)-adrenergic receptor (ADRB1), beta(2)-adrenergic receptor (ADRB2), beta(3)-adrenergic receptor (ADRB3), and alpha(2)-adrenergic receptor (ADRA2A) genes associate with obesity and metabolic alterations, we recruited 74 healthy African American and 161 white men and women (age, 18-49 years) to participate in this case-control genetic association study. Genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism. Associations between genotype and body mass index (BMI), percentage of body fat (by measuring skinfold thickness in 7 different sites), fasting (12-hour) plasma glucose, insulin, potassium concentrations, glycated hemoglobin, and insulin resistance (homeostasis model assessment [HOMA(IR)] score) were performed. Among whites, the ADRB1 Arg389-->Gly variant associated with insulin concentrations and HOMA(IR): mean +/- SD values for insulin and HOMA(IR) in Arg389 homozygotes and carriers of the Gly were 10 +/- 7.0 and 12 +/- 9.4 micro IU/mL (P = .02) and 2.1 +/- 1.7 and 2.6 +/- 2.2 (P = .057), respectively. Systolic blood pressure was higher in whites for carriers of the ADBR1 Ser49 compared to Gly49 homozygotes (124 +/- 12.6 vs 119 +/- 11.3 mm Hg, respectively; P = .02). Subsequent analysis revealed that these associations were attributable to a higher BMI among obese participants. The ADRA2A G1780A SNP associated with BMI and percentage of body fat in African Americans (P = .05). Interactions were detected between ADRA2A C-1291G and ADRB2 Gln27-->Glu variants for obesity in African Americans and between ADRA2A C-1291G SNP and ADBR1 haplotype for obesity in whites. We conclude that common SNPs in adrenergic receptor genes may be important susceptibility loci for obesity and related alterations. Because of the limited size of our populations, our results should be interpreted with caution and should be replicated in larger populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512307      PMCID: PMC2040233          DOI: 10.1016/j.metabol.2007.01.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  52 in total

1.  Use of unlinked genetic markers to detect population stratification in association studies.

Authors:  J K Pritchard; N A Rosenberg
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 2.  Genome-wide association studies for common diseases and complex traits.

Authors:  Joel N Hirschhorn; Mark J Daly
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

3.  Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene.

Authors:  Inna Belfer; Beata Buzas; Heather Hipp; Gabriel Phillips; Julie Taubman; Ilona Lorincz; Catherine Evans; Robert H Lipsky; Mary-Anne Enoch; Mitchell B Max; David Goldman
Journal:  J Hum Genet       Date:  2004-12-08       Impact factor: 3.172

4.  A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.

Authors:  D A Mason; J D Moore; S A Green; S B Liggett
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 6.  Catecholamine-induced lipolysis in obesity.

Authors:  P Arner
Journal:  Int J Obes Relat Metab Disord       Date:  1999-02

7.  beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight.

Authors:  Y Linné; I Dahlman; J Hoffstedt
Journal:  Int J Obes (Lond)       Date:  2005-05       Impact factor: 5.095

Review 8.  The human obesity gene map: the 2005 update.

Authors:  Tuomo Rankinen; Aamir Zuberi; Yvon C Chagnon; S John Weisnagel; George Argyropoulos; Brandon Walts; Louis Pérusse; Claude Bouchard
Journal:  Obesity (Silver Spring)       Date:  2006-04       Impact factor: 5.002

9.  Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue.

Authors:  V Stich; I de Glisezinski; F Crampes; H Suljkovicova; J Galitzky; D Riviere; J Hejnova; M Lafontan; M Berlan
Journal:  Am J Physiol       Date:  1999-10

Review 10.  Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia.

Authors:  V Large; P Arner
Journal:  Diabetes Metab       Date:  1998-11       Impact factor: 6.041

View more
  28 in total

1.  Early redox imbalance is associated with liver dysfunction at weaning in overfed rats.

Authors:  E P S Conceição; E G Moura; J C Carvalho; E Oliveira; P C Lisboa
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

2.  Evaluation of the association between the ADRA2A genetic polymorphisms and type 2 diabetes in a Chinese Han population.

Authors:  Tianjie Li; Xilin Zhu; Xiaopan Wu; Jingyun Li; Liping Pan; Pengtao Li; Zhenhui Xin; Harvest F Gu; Ying Liu
Journal:  Genet Test Mol Biomarkers       Date:  2012-12

Review 3.  {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype.

Authors:  John H Eisenach; Erica D Wittwer
Journal:  Exp Physiol       Date:  2010-04-09       Impact factor: 2.969

4.  Individual Responsiveness to Exercise-Induced Fat Loss and Improvement of Metabolic Profile in Young Women is Associated with Polymorphisms of Adrenergic Receptor Genes.

Authors:  Agata Leońska-Duniec; Zbigniew Jastrzębski; Aleksandra Jażdżewska; Waldemar Moska; Ewelina Lulińska-Kuklik; Marek Sawczuk; Svetlana I Gubaydullina; Alsu T Shakirova; Pawel Cięszczyk; Adam Maszczyk; Ildus I Ahmetov
Journal:  J Sports Sci Med       Date:  2018-03-01       Impact factor: 2.988

Review 5.  What the Genetic Background of Individuals with Asthma and Obesity Can Reveal: Is β2-Adrenergic Receptor Gene Polymorphism Important?

Authors:  Hanna Danielewicz
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-09-01       Impact factor: 1.349

6.  Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population.

Authors:  Rajani Rai; Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-21       Impact factor: 4.553

Review 7.  Very important pharmacogene summary ADRB2.

Authors:  Augusto A Litonjua; Li Gong; Qing Ling Duan; Jaekyu Shin; Mariellen J Moore; Scott T Weiss; Julie A Johnson; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

8.  A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity.

Authors:  Athanasios Papathanasopoulos; Michael Camilleri; Paula J Carlson; Adrian Vella; Sara J Linker Nord; Duane D Burton; Suwebatu T Odunsi; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

9.  A simple and rapid genotyping assay for simultaneous detection of two ADRB2 allelic variants using fluorescence resonance energy transfer probes and melting curve analysis.

Authors:  M Fernanda Sábato; Anne-Marie Irani; Bonny L Bukaveckas; Lawrence B Schwartz; David S Wilkinson; Andrea Ferreira-Gonzalez
Journal:  J Mol Diagn       Date:  2008-05       Impact factor: 5.568

10.  ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.

Authors:  Batoul Kaabi; Ghania Belaaloui; Wassila Benbrahim; Kamel Hamizi; Mourad Sadelaoud; Wided Toumi; Hocine Bounecer
Journal:  Pathol Oncol Res       Date:  2015-11-13       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.